Live Report From ACHEMA
With ACHEMA entering its penultimate day and many visitors preparing to return home after a busy stay in Frankfurt, PTE editor Jo Watts gives her closing thoughts on the show.
Day Three at ACHEMA and I've seen even more innovations. here are some of the highlights.
Medelpharm have a tablet compressor that can make 900 single or 300 triple layer tablets in an hour. It does the entire process. It can make tablets of up to five layers and three different types of powder are possible. A touch of a button allows for the weighing of each layer independently. Each step is monitored for analysis, force, displacement and ejection. It is also remarkably easy to dismantle and reassemble.
Sartorius have a massive array of products at the event. Their Picus pipette won a red-dot award in 2012. It is durable yet light and it claims to protect from RSI. Their Biostat D-DCU is a compact sterilisation in-place bioreactor. It comes in a variety of sizes, from 10L to 200L. Its modular design enables easy configuration to meet individual customer needs.
Sartorius also announced that they have teamed up with BOSCH. Their preVAS system is a complete, pre-validated single-use filling system. It is pre-Validated, pre-Assembled and pre-Sterilised. It is flexible, safe, and quick. What's more it uses the BOSCH peristaltic pump, there is a trolley version, and hybrid versions are available.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
INTERPHEX 2025: Use of Walk-In Chambers for Bio/Pharma Development and Manufacturing
April 2nd 2025Sitting down with the PharmTech Group at INTERPHEX 2025, Christopher Murphy, director of Global Business Development and Service Customer Support at Environmental Specialties, discusses the design and critical role of walk-in chambers in the bio/pharmaceutical industry.
